These results showed that prostatic cell growth was inhibited more by [D-Lys6]-GnRH-MTX than MTX alone, and that [D-Lys6]-GnRH-MTX also decreased tumor volume (74% vs 62% of MTX alone) and tumoral weight (74% vs 63% respectively) (76). Here, GNRH1 is linked to neoplasm.